IDIBELL on the media

aa_system_1

Students of the High School Provençana visit IDIBELL research support platforms

On Tuesday May 6 students of higher technical certificate in Lab of analysis and quality of Provençana Institute of Hospitalet de Llobregat visited the IDIBELL to learn about how research is done. Students had the opportunity to know how some IDIBELL research support platforms work. Specifically, they visited units of proteomics and genomics. This initiative […]

ICO-Hospital Duran i Reinals

Identified two new genes involved in the more aggressive prostate cancer

The study opens the door to distinguish patients who will suffer particularly virulent prostate tumors to personalize treatment Prostate cancer Identify high-risk patients Two new genes in the spotlight

Manel-Esteller-premis

Manel Esteller, awarded the Prize of Honor Dr. Benaprès 2014

The Director of Epigenetics and Cancer Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Research and Professor at the University of Barcelona, ​​Manel Esteller, earned the Award of Honor Dr. Benaprès 2014 for his scientific career, awarded by the Spanish Society of Cosmetic Medicine and Surgery. The award is given for the multiple […]

epi_5

IDIBELL prepares the Human Resources Strategy for Researchers 2014-2017

The European Commission has adopted the “European Charter for Researchers” and the “Code of Conduct for the Recruitment of Researchers” as key elements to encourage the mobility of researchers and the harmonization of their work conditions across Europe. IDIBELL endorsed the principles outlined by these two documents on August 1st 2013. Some of the highlights […]

leyden_2

Students of the University of Leiden visit IDIBELL within their route around the research done Spain

On Monday April 28th, a group of medical students at the University of Leiden, The Netherlands, has known a little bit about the research conducted in the IDIBELL. This visit is part of the study tour that the association of students of the Faculty of Medicine, Leiden organizes every year for several research institutes from […]

logoUPC

IDIBELL, University Hospital of Bellvitge and UPC collaborate to develop new health technologies

IDIBELL, University Hospital of Bellvitge and the Polytechnic University of Catalonia (UPC) have signed a cooperation agreement in the field of education, research and innovation to share knowledge and needs that will allow the development of new health technologies. The agreement establishes a framework for relations between the three institutions for future collaboration in order […]

escolab_1

Brain plasticine’ is back

Past April 1st, 2nd and 3rd, students in 1 º ESO at IES Joan Corominas, Premia de Mar and students of 3 º ESO at IES Montjuïc, Barcelona discovered how our brain changes and also how sometimes it deceives us. They participated in the activity ‘ Brain plasticine’ organized by the research group cognition and […]

presentaci_revents1

Jaume Reventós: “Together we can move forward”

On Wednesday April 2, the auditorium of the University Hospital of Bellvitge hosted the presentation of the new IDIBELL general manager, Jaume Reventós. The event was attended by members of the delegate Commission of the institution Jordi Alberch , Vice Chancellor of the University of Barcelona ; Alfredo Garcia Director of the University Hospital of […]

dna-g3cca42711_1920

Identified epigenetic factors associated with an increased risk of developing cancer

Research shows that in one in four human tumor exist genetic polymorphisms associated with increased risk of cancer that cause epigenetic changes that modifies the expression of neighboring genes.

fabregat_grup

IDIBELL researchers describe a new tumor suppressor gene in the liver

NOX4 enzyme inhibits the growth of tumor cells in liver Article reference The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression

Scroll to Top